Xanthi Yiakoumis

Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy

Christina Kalpadakis, Gerassimos A. Pangalis, Maria K. Angelopoulou et al. · The Oncologist · 2013 · 87 citations · Full text

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Christina Kalpadakis, Gerassimos A. Pangalis, Sotirios Sachanas et al. · Blood · 2018 · 57 citations · Full text

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen

Sotirios Sachanas, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 36 citations

Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients

Christina Kalpadakis, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 35 citations

Hematological Malignancy, Lymphoid Neoplasia, Ann Arbor Stage +10

Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:msup><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mrow><mml:mtext>Tyr</mml:mtext></mml:mrow></mml:msup><mml:mtext>p</mml:mtext></mml:math>-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance

Georgia Levidou, Sotirios Sachanas, Gerassimos A. Pangalis et al. · BioMed Research International · 2014 · 24 citations · Full text